Risque hémorragique de l’apixaban versus le rivaroxaban dans le traitement des thromboses veineuses aiguës profondes
Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism
Castellucci LA, Chen WN, Kovacs MJ et al for the COBRRA (Comparison of Bleeding Risk between Rivaroxaban and Apixaban) Trial Investigators.
New Engl J Med 2026;394:1051-60.
https://doi.org/10.1056/NEJMoa2510703
